Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Commentary & Opinion

No One Funding Model Is Sufficient to Ensure Availability of Life-Saving Drugs

April 6, 2012

"Trade deals are threatening generic drugs -- we need new ways to incentivize affordable drug development," Daniele Dionisio, head of the research project Geopolitics, Public Health and Access to Medicines (GESPAM) and a member of the European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases, writes in this SciDev.Net opinion piece. "Just under three billion people live on less than $2 per day, in resource-limited countries where key medicines protected by patents are unaffordable," he writes, adding, "Free-trade deals, such as the Trans-Pacific Partnership Agreement, and governments adopting intellectual property (IP) policies that favor the brand pharmaceutical sector are also threatening the trade of legitimate generic medicines."

"To ensure long-term access to medicines, the WHO has called for operational models to finance research and development (R&D) for diseases of the poor," he continues, adding, "But any one model will not be enough to ensure the availability of life-saving drugs." He notes, "The WHO's models include direct grants, equitable licensing, pooled funds, prizes and patent pools, collectively called 'best fitting' models," and discusses each in detail. "A financial transaction tax (FTT), which aims to support development and health needs, is now under international debate, and has been endorsed by the E.U. Commission," Dionisio writes, concluding, "The FTT should be introduced, enforced and implemented worldwide. It would be instrumental, alongside the models proposed by the WHO, to promoting R&D to develop medicines for diseases of the poor" (4/5).

Back to other news for April 2012


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More on Generic/Discount HIV Drug Access in the Developing World
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement